drugset / Trial / NCT00901823

Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline

NCT00901823 ↗

Phase 1 Withdrawn Essentialis, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This is a single-center, randomized, open-label, single- and multiple-dose, five-treatment, two-period, four-way parallel study comparing the pharmacokinetics (PK) of Diazoxide Choline Controlled-Release Tablet (DCCR) administered orally under fed and fasting conditions at two dose levels.

Timeline

Start
2011-03
Primary completion
2011-03
Completion
2011-03

Outcome

Outcome not reported

Stopped: “Did not support the planned development of DCCR in the new indication”

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazoxide Choline Unknown — Oral

Indications